{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:51:58Z","timestamp":1760233918693,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Kallmann syndrome is the result of innate genetic defects in the fibroblast growth factor (FGF) regulated signaling network causing diminished signal transduction. One of the rare mutations associated with the syndrome alters the Sprouty (Spry)4 protein by converting the serine at position 241 into a tyrosine. In this study, we characterize the tyrosine Spry4 mutant protein in the primary human embryonic lung fibroblasts WI-38 and osteosarcoma-derived cell line U2OS. As demonstrated in a cell signaling assay, Spry4 gains the capability of inhibiting FGF, but not epithelial growth factor (EGF)-induced signaling as a consequence of the tyrosine substitution. Additionally, migration of normal embryonic lung fibroblasts and osteosarcoma-derived cells is potently inhibited by the tyrosine Spry4 variant, while an effect of the wildtype Spry4 protein is hardly measureable. Concerning cell proliferation, the unaltered Spry4 protein is ineffective to influence the WI-38 cells, while the mutated Spry4 protein decelerates the cell doubling. In summary, these data emphasize that like the other mutations associated with Kallmann syndrome the described Spry4 mutation creates a hyperactive version of a selective inhibitory molecule and can thereby contribute to a weakened FGF signaling. Additionally, the study pinpoints a Spry4 variation expanding the applicability of Spry4 in a potential cancer therapy.<\/jats:p>","DOI":"10.3390\/ijms22042145","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T22:04:15Z","timestamp":1613945055000},"page":"2145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes"],"prefix":"10.3390","volume":"22","author":[{"given":"Astrid","family":"St\u00fctz","sequence":"first","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Z. M.","family":"Kamptner","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-9299","authenticated-orcid":false,"given":"Hedwig","family":"Sutterl\u00fcty","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tem.2010.01.004","article-title":"Novel insights in fgfr1 regulation: Lessons from kallmann syndrome","volume":"21","author":"Hu","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-18-0764","article-title":"New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism","volume":"181","author":"Amato","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fendo.2019.00781","article-title":"A rare spry4 gene mutation is associated with anosmia and adult-onset isolated hypogonadotropic hypogonadism","volume":"10","author":"Indirli","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jmedgenet-2019-106786","article-title":"Prevalence and associated phenotypes of dusp6, il17rd and spry4 variants in a large chinese cohort with isolated hypogonadotropic hypogonadism","volume":"58","author":"Men","year":"2021","journal-title":"J. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajhg.2013.04.008","article-title":"Mutations in fgf17, il17rd, dusp6, spry4, and flrt3 are identified in individuals with congenital hypogonadotropic hypogonadism","volume":"92","author":"Miraoui","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)80919-8","article-title":"Sprouty encodes a novel antagonist of fgf signaling that patterns apical branching of the drosophila airways","volume":"92","author":"Hacohen","year":"1998","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1242\/dev.126.20.4465","article-title":"Vertebrate sprouty genes are induced by fgf signaling and can cause chondrodysplasia when overexpressed","volume":"126","author":"Minowada","year":"1999","journal-title":"Development"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ncb978","article-title":"Mammalian sprouty4 suppresses ras-independent erk activation by binding to raf1","volume":"5","author":"Sasaki","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ncb867","article-title":"Sprouty1 and sprouty2 provide a control mechanism for the ras\/mapk signalling pathway","volume":"4","author":"Hanafusa","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"41420","DOI":"10.1074\/jbc.M306425200","article-title":"The receptor tyrosine kinase regulator sprouty1 is a target of the tumor suppressor wt1 and important for kidney development","volume":"278","author":"Gross","year":"2003","journal-title":"J. Boil. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1074\/jbc.M508300200","article-title":"The tumor suppressor pten is necessary for human sprouty 2-mediated inhibition of cell proliferation","volume":"281","author":"Edwin","year":"2006","journal-title":"J. Boil. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1091\/mbc.e10-02-0123","article-title":"Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase c","volume":"21","author":"Akbulut","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.devcel.2004.12.004","article-title":"Sprouty1 is a critical regulator of gdnf\/ret-mediated kidney induction","volume":"8","author":"Basson","year":"2005","journal-title":"Dev. Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.devcel.2005.02.009","article-title":"Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing fgf signaling","volume":"8","author":"Shim","year":"2005","journal-title":"Dev. Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nn1485","article-title":"Loss of mammalian sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia","volume":"8","author":"Taketomi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbrc.2006.11.107","article-title":"Sprouty2 and sprouty4 are essential for embryonic morphogenesis and regulation of fgf signaling","volume":"352","author":"Taniguchi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1541-7786.MCR-09-0400","article-title":"Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by wnt7a through ppargamma in non-small cell lung cancer","volume":"8","author":"Tennis","year":"2010","journal-title":"Mol. Cancer Res. MCR"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s13277-013-1587-0","article-title":"Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines","volume":"35","author":"Vanas","year":"2014","journal-title":"Tumour Boil. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Celik-Selvi, B.E., Stutz, A., Mayer, C.E., Salhi, J., Siegwart, G., and Sutterluty, H. (2019). Sprouty3 and sprouty4, two members of a family known to inhibit fgf-mediated signaling, exert opposing roles on proliferation and migration of glioblastoma-derived cells. Cells, 8.","DOI":"10.3390\/cells8080808"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.febslet.2013.06.040","article-title":"Sprouty2 but not sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells","volume":"587","author":"Rathmanner","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ijc.29425","article-title":"Sprouty 2 protein, but not sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer","volume":"137","author":"Amini","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1242\/jcs.02711","article-title":"Efficient suppression of fgf-2-induced erk activation by the cooperative interaction among mammalian sprouty isoforms","volume":"118","author":"Ozaki","year":"2005","journal-title":"J. Cell Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/1541-7786.MCR-07-0255","article-title":"Modulation of endocrine pancreas development but not beta-cell carcinogenesis by sprouty4","volume":"6","author":"Jaggi","year":"2008","journal-title":"Mol. cancer Res. MCR"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36804","DOI":"10.1074\/jbc.C100386200","article-title":"Identification of a dominant negative mutant of sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced erk activation","volume":"276","author":"Sasaki","year":"2001","journal-title":"J. Boil. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1349-7006.2009.01214.x","article-title":"Sprouty4 deficiency potentiates ras-independent angiogenic signals and tumor growth","volume":"100","author":"Taniguchi","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10456-008-9089-1","article-title":"Sprouty proteins, masterminds of receptor tyrosine kinase signaling","volume":"11","author":"Cabrita","year":"2008","journal-title":"Angiogenesis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.109.055848","article-title":"Intermolecular interactions of sprouty proteins and their implications in development and disease","volume":"76","author":"Edwin","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrm1400","article-title":"Modulation of signalling by sprouty: A developing story","volume":"5","author":"Kim","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10555-014-9497-1","article-title":"The developing story of sprouty and cancer","volume":"33","author":"Amini","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/MCB.26.5.1898-1907.2006","article-title":"Regulation of sprouty stability by mnk1-dependent phosphorylation","volume":"26","author":"DaSilva","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0960-9822(03)00086-1","article-title":"Hspry2 is targeted to the ubiquitin-dependent proteasome pathway by c-cbl","volume":"13","author":"Hall","year":"2003","journal-title":"Curr. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1007\/s00018-010-0379-6","article-title":"Bimodal expression of sprouty2 during the cell cycle is mediated by phase-specific ras\/mapk and c-cbl activities","volume":"67","author":"Mayer","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.biocel.2015.04.017","article-title":"The increased sprouty4 expression in response to serum is transcriptionally controlled by specific protein 1","volume":"64","author":"Doriguzzi","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1515\/bc.2010.082","article-title":"Sprouty4 levels are increased under hypoxic conditions by enhanced mrna stability and transcription","volume":"391","author":"Haigl","year":"2010","journal-title":"Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1074\/jbc.M109.030882","article-title":"Hect domain-containing e3 ubiquitin ligase nedd4 interacts with and ubiquitinates sprouty2","volume":"285","author":"Edwin","year":"2010","journal-title":"J. Boil. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jcb.21040","article-title":"Regulation of sprouty2 stability by mammalian seven-in-absentia homolog 2","volume":"100","author":"Nadeau","year":"2007","journal-title":"J. Cell Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/pros.20353","article-title":"Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer","volume":"66","author":"Wang","year":"2006","journal-title":"Prostate"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10456-013-9361-x","article-title":"Sprouty4 regulates endothelial cell migration via modulating integrin beta3 stability through c-src","volume":"16","author":"Gong","year":"2013","journal-title":"Angiogenesis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","article-title":"Fgf signaling in the developing endochondral skeleton","volume":"16","author":"Ornitz","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ng1122","article-title":"Loss-of-function mutations in fgfr1 cause autosomal dominant kallmann syndrome","volume":"33","author":"Dode","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Vanas, V., Haigl, B., Stockhammer, V., and Sutterluty-Fall, H. (2016). Microrna-21 increases proliferation and cisplatin sensitivity of osteosarcoma-derived cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161023"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1541-7786.MCR-06-0273","article-title":"Down-regulation of sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms","volume":"5","author":"Sutterluty","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/12027","article-title":"P45skp2 promotes p27kip1 degradation and induces s phase in quiescent cells","volume":"1","author":"Sutterluty","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cbf.2976","article-title":"In non-small cell lung cancer mitogenic signaling leaves sprouty1 protein levels unaffected","volume":"32","author":"Kral","year":"2014","journal-title":"Cell Biochem. Funct."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/2145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:30Z","timestamp":1760160450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/2145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22042145"],"URL":"https:\/\/doi.org\/10.3390\/ijms22042145","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2021,2,21]]}}}